Similarly, the reduction of CAXII expression by blocking Hedgehog signaling pathway in MDA-MB-231 cells could limit the migration ability of cancer cells, which highlighted the potential role of CAXII to be an effective therapeutic target in TNBC treatment. Here, CA12 is linked to cancer.